Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
93.34 EUR | -1.47% | +2.30% | -0.95% |
Jun. 12 | Syensqo: BlackRock holds 3.65% of the capital | CF |
Jun. 05 | Syensqo: inaugural bond issue finalized | CF |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.62% | 10.81B | - | ||
+5.02% | 78.96B | B | ||
-6.31% | 45B | A- | ||
+4.68% | 33.67B | C | ||
+13.26% | 18.76B | B | ||
+15.66% | 12.22B | A- | ||
-3.32% | 9.1B | A- | ||
-4.02% | 8.41B | C- | ||
-7.29% | 7.51B | B | ||
-12.63% | 5.86B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SYENS Stock
- Ratings Syensqo SA/NV